These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26178915)

  • 1. Liver capsule: Hepatic encephalopathy.
    Bajaj JS
    Hepatology; 2015 Sep; 62(3):955. PubMed ID: 26178915
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic encephalopathy forward to the past.
    Blendis L
    Gastroenterology; 2006 Jun; 130(7):2239-40. PubMed ID: 16762648
    [No Abstract]   [Full Text] [Related]  

  • 3. Covert hepatic encephalopathy: agreement and predictive validity of different indices.
    Montagnese S; Balistreri E; Schiff S; De Rui M; Angeli P; Zanus G; Cillo U; Bombonato G; Bolognesi M; Sacerdoti D; Gatta A; Merkel C; Amodio P
    World J Gastroenterol; 2014 Nov; 20(42):15756-62. PubMed ID: 25400460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hepatic encephalopathy in the era of MELD.
    Thornton JG; Mullen KD
    Liver Transpl; 2007 Oct; 13(10):1364-5. PubMed ID: 17902142
    [No Abstract]   [Full Text] [Related]  

  • 5. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
    Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
    Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of subclinical hepatic encephalopathy.
    Hartmann IJ; Groeneweg M; Quero JC; Beijeman SJ; de Man RA; Hop WC; Schalm SW
    Am J Gastroenterol; 2000 Aug; 95(8):2029-34. PubMed ID: 10950053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of the cirrhotic patient].
    Pfefferle M; Bihl F; Terziroli B; Cerny A
    Ther Umsch; 2011 Apr; 68(4):207-11. PubMed ID: 21452142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation of patients in end-stage cirrhosis.
    Haydon GH; Neuberger J
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):1049-73. PubMed ID: 11139354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of hypokalemia in hepatic encephalopathy.
    Gaduputi V; Chandrala C; Abbas N; Tariq H; Chilimuri S; Balar B
    Hepatogastroenterology; 2014; 61(133):1170-4. PubMed ID: 25436277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent prognostic factors in patients with liver cirrhosis.
    Piekarska A; Zboinska J; Szymczak W; Kuydowicz J
    Hepatogastroenterology; 2008; 55(84):1034-40. PubMed ID: 18705324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients with advanced liver cirrhosis.
    Sargent S
    Nurs Stand; 2006 Nov 22-28; 21(11):48-56; quiz 58. PubMed ID: 17165484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of mortality in cirrhosis of the liver.
    Lecompte Y; Metreau JM; Sancho HS; Bismuth H
    Surg Gynecol Obstet; 1974 Oct; 139(4):529-30. PubMed ID: 4608304
    [No Abstract]   [Full Text] [Related]  

  • 14. QTc interval prolongation and hepatic encephalopathy in patients candidates for liver transplantation: A valid inference?
    Marafioti V; Benetti V; Montin U; Carbone V; Petrosino A; Tedeschi U; Rossi A
    Int J Cardiol; 2015 Jun; 188():43-4. PubMed ID: 25885747
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimal treatment of hepatic encephalopathy.
    Allampati S; Mullen KD
    Minerva Gastroenterol Dietol; 2016 Dec; 62(4):296-304. PubMed ID: 27763575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathophysiology, diagnosis, and management of acute hepatic encephalopathy.
    Colquhoun SD; Lipkin C; Connelly CA
    Adv Intern Med; 2001; 46():155-76. PubMed ID: 11147252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatic encephalopathy in patients with cirrhosis: new aspects and practical recommendations].
    Ditisheim S; Spahr L
    Rev Med Suisse; 2010 Sep; 6(261):1667-71. PubMed ID: 20939401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
    Inoue H; Emori K; Toyonaga A; Oho K; Kumamoto M; Haruta T; Mitsuyama K; Tsuruta O; Sata M
    Kurume Med J; 2014; 61(1-2):1-8. PubMed ID: 25420513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic encephalopathy and hepatopulmonary syndrome].
    Böker KH
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S241-4. PubMed ID: 16435726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.